孤立性髂总动脉瘤单纯采用髂分支支架移植物治疗:多中心登记研究中期结果
多中心登记研究评估了46例孤立性髂总动脉瘤患者仅用髂分支装置(IBD)而无主动脉支架的中远期结局。41例男性纳入分析,30天死亡率和IBD闭塞率分别为2.4%和2.3%。1年和5年累积生存率、装置通畅率和免于再干预率分别为90.2%、95.2%和95.7%,无内漏、移位或断裂。作者认为孤立性IBD是解剖合适病例稳定持久的腔内重建方式,但需更长期随访和更大样本验证。
要点
- 孤立性髂总动脉瘤仅用IBD治疗,1年和5年累积生存率90.2%、装置通畅率95.2%、免于再干预率95.7%。
- 30天死亡率和IBD闭塞率分别为2.4%和2.3%,影像随访未见内漏、装置移位或断裂。
- 1年时38例存活者中21例髂总动脉瘤缩小≥5 mm,作者认为IBD是解剖合适病例稳定持久的腔内重建方式。
核心结论
- 孤立性髂总动脉瘤仅用IBD而不加主动脉支架,通畅性优异、并发症和死亡率低,无内漏或移位且再干预率低,支持孤立性IBD作为解剖合适病例稳定持久的腔内重建方式。
- 作者指出需更长期随访和更大队列验证这些结果。
研究设计与样本
- 多中心登记研究,2006年12月至2016年6月共7个血管中心纳入46例患者的49个孤立性髂总动脉瘤,均仅用IBD治疗。
- 5例失访,最终分析41例男性患者,平均年龄72.5±7.8岁,平均髂总动脉瘤直径39.1±10.5 mm(范围25-65)。
- 32例患者(2例双侧髂总动脉瘤)使用Cook Zenith髂分支装置,9例患者(1例双侧)使用Gore Excluder髂分支内假体。
主要发现
- 30天死亡率为2.4%,IBD闭塞率为2.3%。
- 平均随访40.2±33.9个月,无患者出现臀部跛行、勃起功能障碍或肠缺血或脊髓缺血;3例患者在术后6个月内死亡。
- 1年和5年累积生存率、装置通畅率和免于再干预率估计分别为90.2%、95.2%和95.7%。
- 1年时38例存活者中21例记录到髂总动脉瘤缩小≥5 mm;影像随访未见内漏、装置移位或断裂的证据。
局限性
- 作者指出需更长期随访和更大队列验证这些结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess early and midterm outcomes of iliac branch device (IBD) implantation without an aortic stent-graft for the treatment of isolated common iliac artery aneurysm (CIAA). METHODS: From December 2006 to June 2016, 49 isolated CIAAs in 46 patients were treated solely with an IBD at 7 vascular centers. Five patients were lost to follow-up, leaving 41 male patients (mean age 72.5±7.8 years) for analysis. Mean CIAA diameter was 39.1±10.5 mm (range 25-65). Thirty-two patients (2 with bilateral CIAAs) were treated with a Cook Zenith iliac branch device; 9 patients (1 bilateral) received a Gore Excluder iliac branch endoprosthesis. Primary endpoints were technical success, survival, aneurysm exclusion, device patency, and freedom from reintervention at 1 and 5 years. Freedom from major adverse events and aneurysm shrinkage at 1 year were also assessed. RESULTS: Thirty-day mortality and the IBD occlusion rate were 2.4% and 2.3%, respectively. At a mean follow-up of 40.2±33.9 months, no patient presented buttock claudication, erectile dysfunction, or bowel or spinal cord ischemia. Three patients died within 6 months after the procedure. Estimates of cumulative survival, device patency, and freedom from reintervention were 90.2%, 95.2%, and 95.7%, respectively, at 1 and 5 years. At 1 year, CIAA shrinkage ≥5 mm was recorded in 21 of 38 survivors. No evidence of endoleak, device migration, or disconnection was found on imaging follow-up. CONCLUSION: The use of IBDs without an aortic stent-graft for isolated CIAAs resulted in excellent patency, with low morbidity and mortality. This, in conjunction with no endoleak or migration and a low reintervention rate, supports the use of isolated IBDs as a stable and durable means of endovascular reconstruction in cases with suitable anatomy. Longer follow-up and a larger cohort are needed to validate these results.
引用
- Giaquinta A, Ardita V, Ferrer C, et al. Isolated Common Iliac Artery Aneurysms Treated Solely With Iliac Branch Stent-Grafts: Midterm Results of a Multicenter Registry. J Endovasc Ther. 2018. PMID: 30141378. doi:10.1177/1526602818754862
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。